Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | News
Search Refinements

Contract Research News

View news from other Pharmaceutical sectors:
91-105 of 2101 results
Lixte licenses LB-100 anti-cancer compound to Taipei Medical University
By PBR Staff Writer
Lixte Biotechnology has granted an exclusive license of its lead anti-cancer compound, LB-100, to Taipei Medical University (TMU).
Contract Research & Services > Contract Research > News
Bayer, CRISPR to create JV to develop new gene therapies
By PBR Staff Writer
Bayer and CRISPR Therapeutics have agreed to establish a joint venture (JV) to develop new treatments for curing blood disorders, blindness and congenital heart disease.
Contract Research & Services > Contract Research > News
Arsia Therapeutics, Biogen sign research collaboration to develop subcutaneous biologics
Arsia Therapeutics, a Cambridge based company, has announced a collaboration with Biogen.
Contract Research & Services > Contract Research > News
UCLA, Bristol-Myers Squibb join hands for immuno-oncology research
By PBR Staff Writer
Bristol-Myers Squibb (BMS) and the University of California, Los Angeles (UCLA) have signed a collaboration agreement as part of immuno-oncology rare population malignancy (I-O RPM) research program in the US.
Contract Research & Services > Contract Research > News
AstraZeneca collaborates with Wallenberg Centre for Protein Research
AstraZeneca and its global biologics research and development arm, MedImmune, have formed a three-year collaboration with the newly established Wallenberg Centre for Protein Research (WCPR).
Contract Research & Services > Contract Research > News
BMS establishes Center for Molecular Synthesis in collaboration with Princeton University
Bristol-Myers Squibb (BMS) and the Department of Chemistry at Princeton University today announced a new research collaboration, which includes the establishment of the Center for Molecular Synthesis (BMS-CMS).
Contract Research & Services > Contract Research > News
Amgen, Merck collaborate for two cancer immunotherapy trials
By PBR Staff Writer
Amgen and Merck have collaborated to evaluate a class of drugs that use the body’s immune system to fight cancer.
Contract Research & Services > Contract Research > News
Morphotek, Wisconsin university to study immunosuppressive effects of CA125 tumor antigen
Morphotek, a subsidiary of Eisai, has entered into a collaborative research agreement with University of Wisconsin-Madison (UW-Madison) to elucidate the immunosuppressive effects of the CA125 tumor antigen on the investigational monoclonal antibody farletuzumab.
Contract Research & Services > Contract Research > News
Zymeworks, GSK sign antibody collaboration deal
By PBR Staff Writer
Zymeworks has signed a collaboration and license agreement with GlaxoSmithKline (GSK) to develop and commercialize new Fc-engineered monoclonal and bi-specific antibody therapeutics.
Contract Research & Services > Contract Research > News
US researchers re-engineer CRISPR-Cas9 system to minimize gene editing errors
Researchers at the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT have re-engineered the CRISPR-Cas9 genome system to minimize gene editing errors.
Contract Research & Services > Contract Research > News
Children’s cancer death rates drop by 24% in last decade
The rate of children dying from cancer has dropped by 24% in the last decade, according to new figures published by Cancer Research UK.
Contract Research & Services > Contract Research > News
Brickell Biotech secures rights to ROR gamma inhibitors for psoriasis
By PBR Staff Writer
Brickell Biotech has secured the exclusive global rights to a series of novel retinoic acid–related orphan nuclear receptor gamma (RORγ) inhibitors from Orca Pharmaceuticals and New York University.
Contract Research & Services > Contract Research > News
LSP, Bristol-Myers Squibb partner to work on immuno-oncology innovation in Europe
By PBR Staff Writer
Life Sciences Partners (LSP) and Bristol-Myers Squibb have collaborated to find out European breakthrough technologies and products in immuno-oncology and other areas.
Contract Research & Services > Contract Research > News
Lilly, Merck extend immuno-oncology collaboration
Eli Lilly and Company and Merck have extended their immuno-oncology collaboration with Phase III nonsquamous non-small cell lung cancer trial (NSCLC).
Contract Research & Services > Contract Research > News
Servier exercises option to buy rights to Cellectis' UCART19 immunotherapy candidate
By PBR Staff Writer
Servier has exercised its option with Cellectis to acquire exclusive worldwide rights to UCART19, a TALEN gene-edited allogeneic chimeric antigen receptor T-cell (CAR-T) immunotherapy.
Contract Research & Services > Contract Research > News
91-105 of 2101 results